Batia Avni

2.5k total citations
66 papers, 1.4k citations indexed

About

Batia Avni is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Batia Avni has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 24 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Batia Avni's work include Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (11 papers) and CAR-T cell therapy research (11 papers). Batia Avni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Acute Myeloid Leukemia Research (11 papers) and CAR-T cell therapy research (11 papers). Batia Avni collaborates with scholars based in Israel, United States and Australia. Batia Avni's co-authors include Maya Koren‐Michowitz, Sigal Grisariu, Drirh Khare, Reuven Or, Igor Resnick, Dina Ben‐Yehuda, Polina Stepensky, Osnat Almogi‐Hazan, Eran Leitersdorf and Itamar Raz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Batia Avni

63 papers receiving 1.3k citations

Peers

Batia Avni
Melek Ergin Türkiye
Batia Avni
Citations per year, relative to Batia Avni Batia Avni (= 1×) peers Melek Ergin

Countries citing papers authored by Batia Avni

Since Specialization
Citations

This map shows the geographic impact of Batia Avni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Batia Avni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Batia Avni more than expected).

Fields of papers citing papers by Batia Avni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Batia Avni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Batia Avni. The network helps show where Batia Avni may publish in the future.

Co-authorship network of co-authors of Batia Avni

This figure shows the co-authorship network connecting the top 25 collaborators of Batia Avni. A scholar is included among the top collaborators of Batia Avni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Batia Avni. Batia Avni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nachmias, Boaz, Shlomo Elias, Eran Zimran, et al.. (2025). Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin. Frontiers in Immunology. 16. 1526513–1526513. 1 indexed citations
2.
Zuckerman, Tsila, Ron Ram, Batia Avni, et al.. (2023). Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality. International Journal of Molecular Sciences. 25(1). 422–422. 1 indexed citations
3.
Zimran, Eran, et al.. (2023). Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(8). 505.e1–505.e8. 1 indexed citations
4.
Khare, Drirh, Reuven Or, Amnon Buxboim, et al.. (2023). Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Apoptosis, TNF Alpha and Interferon Gamma Response Gene mRNA Expression in T Lymphocytes. International Journal of Molecular Sciences. 24(18). 13689–13689. 4 indexed citations
5.
McGuirk, Joseph P., Leland Metheny, Luis Piñeiro, et al.. (2023). Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study. Bone Marrow Transplantation. 58(11). 1189–1196. 2 indexed citations
6.
Vainstein, Vladimir, Batia Avni, Sigal Grisariu, et al.. (2023). Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?. Cancers. 15(13). 3471–3471. 8 indexed citations
7.
Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations
8.
Beyar‐Katz, Ofrat, Chava Perry, Efrat Luttwak, et al.. (2023). Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study. European Journal Of Haematology. 111(1). 63–71. 4 indexed citations
9.
Aumann, Shlomzion, Boaz Nachmias, Dina Ben Yehuda, et al.. (2023). Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality. European Journal Of Haematology. 111(1). 135–145. 1 indexed citations
10.
Henig, Israel, Ronit Leiba, Ron Ram, et al.. (2023). Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Vaccines. 11(4). 775–775. 3 indexed citations
11.
Assayag, Miri, Batia Avni, Shlomit Kfir‐Erenfeld, et al.. (2023). Early lymphocyte collection for anti‐CD19 CART production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma. British Journal of Haematology. 202(1). 74–85. 15 indexed citations
12.
Grisariu, Sigal, Mila Rivkin, Polina Stepensky, et al.. (2023). High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients. Clinical Transplantation. 37(11). e15098–e15098. 4 indexed citations
13.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2022). Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical Cancer Research. 28(23). 5156–5166. 21 indexed citations
14.
Bavli, Danny, et al.. (2021). Delineating the heterogeneity of matrix-directed differentiation toward soft and stiff tissue lineages via single-cell profiling. Proceedings of the National Academy of Sciences. 118(19). 30 indexed citations
16.
Shimony, Shai, Moshe Yeshurun, Ofir Wolach, et al.. (2021). Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients – a multicenter retrospective observational study. Leukemia & lymphoma. 62(10). 2475–2481. 3 indexed citations
17.
Pasvolsky, Oren, Liat Shargian, Uri Rozovski, et al.. (2021). Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation. Leukemia & lymphoma. 62(11). 2747–2754. 5 indexed citations
18.
Shadur, Bella, Irina Zaidman, Adeeb NaserEddin, et al.. (2018). Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning. Pediatric Blood & Cancer. 65(6). e27010–e27010. 25 indexed citations
19.
Avni, Batia, et al.. (2009). Aortic stiffness in normal and hypertensive pregnancy. Blood Pressure. 19(1). 11–15. 38 indexed citations
20.
Khamaisi, Mogher, Eran Regev, Noam Yarom, et al.. (2006). Possible Association between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis. The Journal of Clinical Endocrinology & Metabolism. 92(3). 1172–1175. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026